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Abstract  
In the present study, out of the total 100 patients studied, 75 patients (75%) were males and majority of 
patients were in 50-75 age group and complained of dysphagia. It was found that the most common site 
of incidence of oral cancer in tobacco and betel quid chewers was buccal mucosa. The aim of this study 
is to further examine the relationship between p53 expression with different histological grades in oral 
squamous cell carcinoma (OSSC) patients from north India. It was found that there was no p53 
expression in normal tissues while in oral SCC patients with tobacco and betel quid chewing habit, the 
percentage of positive cases as well as p53 positivity showed an increase with increasing grade of SCC. 
The expression of p53 was significantly associated with histological grade in oral cancer in tobacco and 
betel quid chewers. In case of p53 expression, statistically significant difference in p53 positivity was 
observed only on comparing well differentiated SCC with poorly differentiated SCC. The expression of 
p53 was not similar in different sites of oral cavity but was more frequently seen in gingivia, floor of 
mouth, tongue, and buccal mucosa. 
American Journal of Cancer Science 
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Introduction  
Oral cancer is sixth most common cancer worldwide and third most common cancer in developing 
countries accounting for about up to 40% of all cancers [1]. Incidence of oral cancer is increasing day 
by day due to more intake of various forms of tobacco and alcohol drinking, which are considered to 
be the two most important etiological factors in the development of oral cancer [2]. It is estimated that 
75-90% of all head and neck cancers are caused due to the tobacco use and tobacco users are between 
20-40 times more likely to develop head and neck cancer than non consumers, depending upon the 
amount of use as well as the age, sex and race of the user [3].   
Tobacco may be taken in various ways like smoking, chewing, etc. The most common form of 
tobacco chewing in India is betel quid. The 'quid' for chewing consists of areca nut and pieces of 
unripe betel fruit or areca nut wrapped in a piece of betel leaf together with white or red lime. Betel 
quid chewing has a strong association with oral cancer which arises predominantly from surface 
epithelium with evolution from early premalignant lesions. Oral Squamous Cell Carcinoma arise as a 
consequence of multiple molecular events induced by the effects of various carcinogens from habits 
such as areca nut and betel quid chewing, influenced by environmental factors, possibly viruses in 
some instances, against a background of inheritable resistance or susceptibility [4]. An individual 
difference in the susceptibility to chemical carcinogens is one of the most important factors in the 
estimate of risk of human cancer as some patients appear susceptible because of inherited trait(s) in 
their ability or inability to metabolize carcinogens or pro-carcinogens, possibly along with an impaired 
ability to repair DNA damage [5].    
Oral carcinogenesis is a multi-step process in which 6-10 genetic events lead to the disruption 
of the normal regulatory pathways that control basic cellular functions. In recent years, several 
alterations in the expression of tumor suppressor genes and oncogenes in the development of Oral 
Squamous Cell Carcinoma (OSCC) have been described [6-8]. Keeping in view above facts, the 
present study was done to investigate the expression of p53 (product of tumor suppressor gene) and to 
further examine the relationship between p53 expression with different histological grades in oral 
squamous cell carcinoma (OSSC) patients from north Indian patients with tobacco and betel quid 
chewing habit.   
Material and methods 
Tissue specimens 
Biopsy tissue specimens from 60 untreated primary Oral Squamous cell Carcinoma (45 men and 15 
women) were obtained from Department of Otorhinolaryngology (ENT), Jawaharlal Nehru Medical 
College, Aligarh Muslim University, Aligarh India (Northern India) from Nov, 2004 up to May, 2007. 
The patients were grouped into 4 age groups: 0-25, 25-50, 50-5 and above 5 years. The tumors were 
classified into grades I, II, III according to their cellular differentiation which is equivalent to well, 
moderately and poorly differentiated tumors. Clinicopathological information including age, gender, 
areca nut and betel quid intake history, location and histological grade was obtained in each case.  
Immunohistochemical staining 
Preparation of sections  
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Formalin fixed, paraffin embedded sections were mounted on slides coated with poly-L-lysine solution. 
The sections mounted on coated slides were incubated at 56 oC overnight for better adhesion. Sections 
were deparaffinized in xylol and hydrated through graded alcohols to Tris buffer saline (0.005 M TRIS 
buffer, pH7.6). Antigen retrieval was done using citrate buffer (0.01 mol/L, pH 6.0) in a pressure 
cooker by heating up to one whistle and then allowing to cool to room temperature before opening the 
lid of cooker. Endogenous peroxidase activity was blocked by treating sections with 3% hydrogen 
peroxide in methanol (LSAB Kit) for 10-15 min. [9, 10].   
Immunostaining   
Primary antibody (FL-393 antibody, Santa Cruz Biotechnology, USA for p53) was added to the 
sections at room temperature and incubated overnight at 38 oC in a moist chamber. The sections were 
then washed with three changes of TBS for 10 min. each and were incubated in biotinylated secondary 
(Link) antibody at room temperature for 30 minutes in a moist chamber and washed in TBS(x3) for 10 
min. duration each. Sections were incubated in streptavidin at room temperature for 45 min. in moist 
chamber and washed in TBS and were incubated in freshly prepared 3, 3’ diaminobenzidine 
tetrahydrochloride (DAB) solution. This was prepared by diluting DAB chromogen (1 drop) in 1 ml of 
DAB substrate. DAB was then used as the substrate for localizing antibody binding Sections were 
washed in distilled water, counterstained in hemotoxylin (1-2 dips), dehydrated through graded 
alcohols, cleaned in xylol and mounted in DPX. The positive control slides were incubated with 
primary antibody whereas in negative controls, primary antibodies were replaced with normal mouse 
serum.  
For protein expression, only nuclear positivity (strong brown staining) was assessed 
quantitatively. Only the percentage was quantified and the percentage of positively stained cells in the 
whole layer of epithelium was determined by scanning the entire section and was recorded by 
assigning cases to one o the our following categories: (a) 0 = No epithelial cells stained, (b) + = up to 
25% of cells positive, (c) ++ = 26 to 50% of cells positive, (d) +++ = > 50% of cells positive. 
This quantification of protein positivity was done according to the method recommended by already 
known workers [9, 10].    
Statistical Analysis 
An SPSS for windows computer programme (SPSS Inc. Chicago 11, USA, version 13) was used for 
statistical analysis. The association between protein expression and tumor location was analyzed by 
the Chi-square test. The relationship between protein expression and histolopathological grade was 
analyzed by Kruskal-Wallis analysis of variance (ANOVA). Wilcoxon paired sample test was used to 
analyze the differences within the three categories of histopathological grade and protein expression. A 
p value of less than 0.05 was accepted as statistically significant.   
Results  
Age incidence 
In the present series, patients belonged to age group of 25-100 years, out of which maximum 
incidence of cases (n=62) was seen in 50-75 years of age group (62% of cases). Only 20% 
(n=20) and 18% (n=18) cases were in the age group of 25-50 years and 75-100 years 
respectively (Table 1). In controls, 50-75 age group predominated with 60% (n=90) of the 
controls belonging to this age group. Only 6.66% (n=10), 18% (n=27) and 15.33 % (n=23) were 
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in the 0-25, 25-50 and 75-100 age group, respectively.   
 
Table 1 Occurrence of oral cancer in different age group of patients  
CATEGORY CASES CONTROLS 
Age Group (years) Male Female Total Male Female Total 
0-25 0 0 0 7 3 10 
25-50 13 07 20 21 6 27 
50-75 48 14 62 68 22 90 
75-100 14 04 18 19 04 23 
Total 75 25 100 125 35 150 
 
Sex incidence     
Out of the total 100 cases studied, 75 cases (75%) were males and rest (25%) were female, 
male-female ratio being 3:1 (Table 2). Out of 150 controls, 115 (76.66%) were males and rest 35 
(23.33%) were females, male-female ratio being 3.28:1 (Table 2).    
 
Table 2 Number and percentage of patients in different sex groups  
Category  Cases Controls 
Sex Number Percentage Number Percentage 
Male 75 75%  115 76.6% 
Female 25 25% 35 23.33% 
Total 100 100% 150 100% 
  
Mean age of male and female cases were 58 years and 53 years, respectively and average 
age of cases was 56.75 years (Table 3). Mean age of male and female controls was 56 years and 
54 years, respectively and average age of controls was 55.53 years.   
 
Table 3 Mean age of patient in different sex groups 
Category Cases Controls 
Sex Number Mean age Number Mean age 
Male 75 58 115 56 
Female 25 53 35 54 
Total 100 56.75  150 55.53  
 
Duration of symptoms 
Most of cases (68.97%) presented with some complaint within first 6 months of the start of the 
lesion. Only 23.72% presented after 6 months to 1 year while 5.83% and 1.45% presented 
symptoms after 12 months and 18 months respectively (Table 4). 
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Table 4 Duration of initial presentation of clinical symptoms by patients 
            Duration (in months) 
 
Presenting Complaint 
 
    <6 
 
6-12 
 
12-18 
 
18-24 
 Difficulty in swallowing 
 Burning in mouth & throat 
 Pain during swallowing 
 Swelling in neck 
 Change in voice 
 Pain in the lesion  
 Pain in the ear  
 Difficulty in opening the mouth 
 Difficulty in speech 
      Bleeding from the mouth 
      Increased salivation 
55 
35 
15 
13 
06 
36 
06 
07 
03 
06 
07 
14 
08 
14 
07 
03 
11 
04 
- 
01 
01 
02 
10 
- 
- 
- 
01 
02 
02 
- 
- 
- 
     01 
01 
02 
- 
- 
- 
01 
- 
- 
- 
- 
- 
Total 189 65 16 04 
Percentage 68.97% 23.72
% 
5.83% 1.45
% 
 
Symptoms of patients 
Most of the patients presented with multiple symptoms with difficulty in swallowing being the 
most common symptom (80 cases). Pain in the lesion (50 cases), burning in the mouth and throat 
(45 cases) and pain during swallowing (29 cases) were the next common symptoms. Other 
complaints were less common as shown in Table 5. 
 
Table 5 Number of cases showing occurrence of different symptoms 
 
S. No. Presenting Complaint o. of cases 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
Difficulty in swallowing 
Pain in the lesion  
Burning in mouth & throat 
Pain during swallowing 
Swelling in neck 
Pain in the ear  
Change in voice  
Increased salivation 
Difficulty in opening the mouth 
Bleeding from the mouth 
Difficulty in speech 
80 
50 
45 
29 
20 
12 
10 
10 
07 
07 
04 
 
 
Relation of tobacco and betel quid chewing with oral cancer 
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Out of 100 cases studied, all 100 (100%) had used tobacco & betel quid. Thirty eight controls 
(out of 150) had used tobacco and betel quid (Table 6).  
 
Table 6 Chi square values of tobacco and betel quid in oral cancer in patients and controls 
                 Disease 
 
Risk factor  
 
Oral Cancer present (cases ) 
 
Oral Cancer absent (Controls) 
 
Total  
Tobacco & betel quid (Exposed) 
100 
(a) 
38 
(b) 
138 
(a+b) 
Non-users 
(Not exposed) 
0 
(c) 
112 
(d) 
112 
(c+d) 
Total 
100 
(a+c) 
150 
(b+d) 
250 
 
 
Exposure Rates  
 Cases  = a/(a+c) = 100/100 = 100% 
 Controls = b/ (b+d) = 38/150  = 25.3% 
 
 This shows that the consumption of tobacco and betel quid is highly related with the 
development of oral cancer as exposure rate among cases is very high i.e. 100% in comparison 
to the low exposure rate of 25.3% among controls. However this cause-effect relationship is 
examined more scientifically on the basis of various other statistical tests like Chi-square test 
(χ2test). 
Chi square test offers an opportunity of testing the significance of difference between 
two proportions. This test is based on the “Null Hypothesis” viz. there is no difference between 
tobacco and betel quid users and non-users in the development of oral cancer. We shall now 
rewrite the previous table showing the observed (O) and expected (E) values in each cell (Table 
7).  
 
Table 7 Exposure of tobacco and betel quid in oral cancer patients and controls to calculate χ2 value. 
 
                 Disease 
 
Risk factor  
Oral Cancer Present Oral Cancer Absent Total 
Tobacco and betel quid chewers O=100 
E=   69 
O=38 
E=69 
138 
Non-users O=0 
E=56 
O=112 
E=56 
112 
Total 125 125 250 
χ2 = Σ (o-E)2/E=135.226 
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The calculated value of χ2 is 135.226 while the value of p (Probability) at 95% level of 
significance for 1 degree of freedom (d.f.) is .000. It means that p<0.001 so it is “Statistically 
significant”. It indicates that our "Null hypothesis" was wrong and there is definite cause-effect 
relationship or we can say that there is strong association between consumption of tobacco and 
betel quid with development of oral cancer. 
Socio Economic Status and Oral Hygiene   
The role of these factors in the predisposition of patients to the development of oral cancer was 
not studied. However it was noted that most of the sufferers belonged to the lower 
socio-economic status and oral hygiene was poor in most of the patients. 
Site of Lesion  
Oral cancer most commonly occurred in buccal mucosa in cases. The incidence of oral cancer in 
different sites of oral cavity is given below (Table 8). 
 
Table 8 The incidence of oral cancer in different sites of oral cavity 
S. No. Site of Lesion No. of Cases Percentage 
 1. 
2. 
3. 
4. 
5. 
6. 
7. 
Tongue 
Buccal mucosa 
Lip 
Hard palate 
Floor of mouth 
Gingivia 
Retromolar region 
22 
45 
06 
05 
17 
03 
02 
22% 
45% 
06% 
05% 
17% 
03% 
02% 
 
Oral cancer most commonly involved buccal mucosa and occurred in 45 cases (45%). 
Next commonly it involved tongue (22%) and floor of mouth (17%) respectively. Other sites are 
less commonly involved. 
Histological Type of Lesion 
All the biopsy samples of the patients were found to be having squamous cell carcinoma on 
histopathological examination (Table 9).  
 
Table 9 Distribution of oral cancer lesion in different histological types 
 
Histological type No. of cases Percentage 
Squamous cell carcinoma 
Adenocarcinoma 
Lymphoepithelioma 
60 
0 
0 
100 
0 
0 
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Immunohistochemical Studies (p53 Protein Expression) 
Tissues of oral SCC patients with tobacco and betel quid chewing habit (60 specimens) and 10 
normal oral tissues were subjected to immunohistochemical staining for expression of p53 using 
FL-393 antibody. Only strong brown nuclear staining of epithelial cells was considered positive. 
Those histological sections with uniform and good intensity were assessed for p53 scoring. The 
scores obtained were expressed as: Positive cases (%) gives the percentage of cases showing 
positive staining with IHC. p53 positivity (%) gives the percentage of cells showing a positive 
staining reaction with p53 IHC. The p53 was expressed in 65% (n=39) of the cases but was not 
expressed in controls. The Figure 1 (A-D) shows the expression of p53 in tobacco and betel 
quid chewers as well as in controls. There were 34(56.6%) cases of well differentiated SCC.   
 
 
Figure 1 (A-D): Immunohistochemical detection of p53 using p53 antibody in tissues obtained from oral 
cancer patients. (A) Representative Figure Showing Expression of p53 in Normal Tissue (B) 
Representative Figure Showing Expression of p53 in Well Differentiated Oral SCC (C) Representative 
Figure Showing Expression of p53 in Moderately Differentiated Oral SCC (D) Representative Figure 
Showing Expression of p53 in Poorly Differentiated Oral SCC.     
18(30%) cases of moderately differentiated SCC and 8(13.3%) cases of poorly 
differentiate SCC. Table 10 depicts the positive cases (%) and mean p53 positivity (%) in oral 
SCC patients and controls along with their sub categories.   
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    Table 10 p53 Expression in oral SCC’s in tobacco and betel quid chewers 
Histological Diagnosis 
Total Cases 
p53 Expression Positivity 
Category 
+ve cases 
(%) 
-ve cases 
 (%) 
Mean + SD Range 
   Oral SCC 60 39(65%) 21(35%) 26.46 ± 23.90  0-75 
a) Well differentiated 34 20(58.8%) 14(41.2%) 20.0+19.32 0-55 
b) Moderately differentiated 18 13(72.22%) 05(27.77%) 29.33+23.50 0-70 
c) Poorly differentiated 08 06(75%) 02(25%) 47.5+31.38 0-75 
   Controls 10 0 10 0 0 
  
 
 
Figure 2 Expression of p53 in oral SCC’s in tobacco and betel quid chewers 
It was found that there was no detectable level of p53 expression in controls (Figure 1A) 
while in oral SCC patients with tobacco and betel quid chewing habit, the percentage of positive 
cases as well as p53 positivity showed an increase with elevated grade of SCC, as evident from 
the Figure 2.   
It was found that expression of p53 was significantly associated with   histological 
grade in oral cancer in tobacco and betel quid chewers (χ2=7.077, df=2, p=0.029). Statistically 
significant difference in p53 positivity was observed on comparing well differentiated SCC (p53 
positivity = 20+19.32) with poorly differentiated SCC (p53 positivity=47.5+31.38, p=0.001) but 
no statistical significance (p=0.27) was observed in p53 positivity between poorly differentiated 
SCC (p53 positivity=47.5+31.38) and moderately differentiated SCC (p53 positivity= 
29.33+23.50), as well as  between well differentiated SCC (p53 positivity= 20+19.32) with 
0
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moderately differentiated SCC (p53 positivity=29.33+23.50, p value =0.27). Expression of p53 
in various sites of oral cavity was investigated and it was found that p53 was more frequently 
expressed in sites like gingivia (1/1, 100%), floor of mouth (5/7, 71%) buccal mucosa (20/31, 
64.5%), tongue (7/10, 70%) and lip (3/5, 60%) while less frequently in sites like hard palate (2/4, 
50%) and retromolar region (1/2, 50%). Further the association between expression of p53 and 
site of incidence of oral cancer was evaluated. It was found that there is no significant 
association between p53 expression and primary site of incidence of oral cancer (χ2 =1.427, 
df=6, p=0.964).   
Discussion 
Age and Sex incidence  
In this study the highest number was between 50-75 years of age group i.e. 62 individuals (62%) 
suffering from cancer. Peak age incidence in Wahi’s series (1958) [11] was 50-54 years while in 
another study by Sankararanayanan et al., (1989) [12], 45% of oral cancer cases were between 
5th & 6th decade. There was no significant difference in age incidence between the age groups 
of patients of our series and that of other workers. The average age in this study was 56.75 years 
in patients in comparison to 54.8 years in the study of A. Nandakumar et al., (1990) [13] and 
50.35 years in the study of D.N. Rao et al., (1994) [14].   
Oral cancer is more common in males as compared to females. A study by G. Krihna et 
al., (1967) reported the incidence of males to be 77.6% [15] while the study by R. Mehrotra et 
al., (2003) have reported about 74% of oral cancer in males [16]. In our series, also, males 
constituted about 75% of the total cases. In Wahi’s series (1958), the male female ratio was 2:1 
[11]. In case control study by G. Krishna et al., (1967), there were 552 males and 224 females i.e. 
2.5:1 ratio [15]. In Mehrotra series (2003), the female ratio was 2.3:1 [16] and in our series, it 
was 3:1. The mean age of male and female cases in our series was 58 and 53 years, respectively 
while the mean age was found to be 63.5 years for males and 60.6 years for females in study by 
Langdon JD et al., (1977) [17].  
Relation of tobacco and betel quid chewing with oral cancer 
  In our study we have observed that tobacco and betel quid chewing is significantly 
associated with development of oral cancer. In India, correlation of tobacco and betel quid 
chewing and smoking with oral cancer has been demonstrated in earlier studies [12, 18-20]. The 
observations made by all of them pointed that the habit of tobacco and betel quid chewing is 
important risk factor in development of oral cancer. Our findings are in accordance with 
observation made by earlier studies.   
Habit of Paan chewing is common in India in both genders. Paan generally includes 
calcium hydroxide, areca nut (from the areca catechu tree) and betel leaf (from the piper betel 
vine). R. Sankaranarayanan et al., (1989) showed that paan-tobacco chewing is major risk factor 
for cancers of buccal and labial mucosa [12]. Similarly Nandakumar et al., (1990) confirmed 
that paan tobacco chewing is a major risk factor in the occurrence of cancers of the oral cavity 
[13]. In the study by P. Balaram et al., (2002), 591 oral cancer cases (309 males and 282 women) 
with 584 hospital controls were taken. They found that most cases of oral cancer in both genders 
were attributed to habit of paan tobacco intake [21].  
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Incidence of site of lesion 
In our series, maximum 45 cases (45%) were of cheek carcinoma (Buccal mucosa) followed by 
malignancy of tongue (22%) and the floor of mouth (17%). In Wahi’s series (1958), cases of 
carcinoma cheek were maximum in the oral cancer patients (53.91%). In a study conducted by 
Rao et al., (1994) [14] the frequency of carcinoma cheek was maximum i.e. 44.4%. In study 
conducted by Agarwal et al., (1999), buccal mucosa was predominant site in betel related oral 
cancer [22]. Ranasinghe et al., (1993) have also shown that buccal mucosa cancer is 
predominant site of oral cancer in tobacco and betel quid chewers [23] while Chang et al., 
(2002) found 57.8% cases of oral cancer to be cheek carcinomas in betel and tobacco related 
oral cancer [24]. Our findings about incidence of site of lesion are in accordance with earlier 
studies.   
p53 Expression   
The immunohistochemical detection of p53 in biopsy specimen as a potential marker is of 
immense interest to researchers, as it is most commonly identified mutated gene in various 
human cancers like lung, breast, prostate and oral cancer. The gene coding for p53 protein i.e. 
TP53 is located on human chromosome 17 P 13:1 and encodes a 53 KDa nuclear phosphoprotein 
that plays an important role in regulation of normal cell proliferation [25, 26]. The wild type p53 
protein has a half life time of 6-20 min. [10] while the mutant form has a half life of several 
hours and can be detected immunohistochemically. The p53 mutations are often associated with 
the development and/or progression of malignant neoplasm [27]. About 90% of mutations at p53 
locus were found to be mis-sense mutations, within the region of exon 5 to 8 [28]. 
Immunohistochemical studies of p53 expression in SCC of oral mucosa have shown 
overexpression of p53 protein [29, 30].   
In  the present study, immunohistochemical studies for p53 expression was done on 
formalin fixed and paraffin embedded tissue sections, using FL-393 antibody (Santa Cruz 
Biotechnology) on biopsy specimens of 60 oral SCC patients with tobacco and betel quid 
chewing habit and 10 controls. Only strong brown nuclear staining was considered positive and 
p53 scoring was done in accordance to literature [9, 10]. The scores were expressed as the 
percentage of positive cases in each category and the percentage of p53 positivity in each case.   
In control specimens who were taken from normal individuals, there was no expression 
of p53 protein. This can be attributed to fact that p53 in its wild form has very short life time 
(16-20 min) and cannot be detected by immunohistochemistry. In present study, increased 
percentage of positive cases as well as mean p53 percent positivity was observed with increasing 
grade of differentiation in oral squamous cell carcinoma (oral SCC) patients with tobacco & 
betel quid chewing habit. The 39 OSCC cases (65%) showed positive p53 expression and mean 
positivity was 26.46 + 23.90. 
Many previous studies have reported similar positivity in oral SCC patients with tobacco 
and betel quid chewing habit. Agarwal et al., (1999) reported that 65.3%   of cases of oral SCC 
with tobacco and betel quid chewing habit showed p53 positivity [22] while Pande et al., (2002) 
reported 65% positivity [29], Jie Xu et al., (1998) reported 59% positivity [31], respectively in 
patients with tobacco and betel quid chewing habit. However lower values were observed by 
Kuttan et al., (1995) and Thongsukai et al., (2001) who reported 56.5% and 38.5% positivity, 
respectively but all researchers reported increase in number of positive cells [30, 32]. 
In our study, we further investigated the expression of p53 in various sites of oral cavity. 
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The p53 expression was more frequently seen in gingivia (100%), floor of mouth (71%), tongue 
(70%) and buccal mucosa (64.5%). There are only few studies which have correlated the 
expression of p53 with site of incidence in oral cavity. Kaur et al., (1998) found that there was 
no association between p53 expression and primary site of cancer (p=0.08) [33]. Similarly 
Claudia et al., (2006) found no association between p53 expression and different oral sites 
(p=0.53) [34]. In our study, expression of p53 was not found to be associated with site of oral 
cancer (p=0.964) thus supporting the earlier studies that p53 expression is independent of site of 
incidence of oral cancer.   
The complete absence of p53 positivity in some squamous cell carcinomas was 
explained by Nylander et al., (2000), as the tumors completely lacking detectable p53 could 
either comprise of wild tumor protein or have a change in function in TP53 gene resulting in 
production of a truncated, non-functional and non detectable protein [35].  
The relationship between p53 expression and tumor grade was also evaluated in our 
study. An increased positivity with increasing grade was observed in the present study. The 
difference was found to be significant between well differentiated (20.0 ± 19.32) and poorly 
differentiated (47.5 ± 31.38) oral SCC, p=.001. However no statistical significance (p=0.27) was 
observed in p53 positivity among poorly differentiated SCC (p53 positivity = 47.5 ± 31.38) and 
moderately differentiated SCC (p53 positivity = 29.33 ± 23.50), as well as between well 
differentiated SCC (p53 positivity = 20 ± 19.32) and moderately differentiated SCC (p53 
positivity = 29.33 ± 23.50), p value =0.27.    
Although most of the known literature have not any shown positive relationship between 
p53 expression and histological grading of oral SCC [36-38]. However, some studies have 
demonstrated a positive correlation between p53 expression and high grade of malignancy [40]. 
In our study, significant association was found between p53 positivity and degree of 
differentiation of tumors (p=0.029). Similar to results in our study, some researchers have found 
a tendency towards higher incidence of p53 positivity in poorly differentiated oral carcinomas 
[40, 41].    
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